Zheng Quan Shi Bao Wang·2025-08-27 09:45Group 1 - A total of 356 buy ratings were issued by institutions today, covering 267 stocks, with China Ping An receiving the highest attention with 6 buy ratings [1] - Among the stocks rated, 100 provided future target prices, with 5 stocks showing an upside potential exceeding 50%, led by Longxin General with a potential increase of 71.48% [1] - 12 stocks received initial attention from institutions today, including Amway and Baofeng Energy, while ratings were upgraded for Guangdong Hongda and Nairui Radar [1] Group 2 - The average decline for stocks with buy ratings was 1.50%, outperforming the Shanghai Composite Index, with notable gainers including Anli Shares and Zhongke Chuangda, which rose by 13.05% and 11.69% respectively [2] - Among the rated stocks, 263 have reported their first-half earnings, with New Special Electric achieving a net profit of 532.87 million yuan, a staggering year-on-year increase of 49,775.01% [2] - The pharmaceutical and biotechnology sector was the most favored, with 30 stocks like Anke Bio and Aier Eye Hospital making the buy rating list, followed by machinery and electronics with 27 and 21 stocks respectively [2]